Regenerative Medicine Conference to Reveal `A Blueprint for the Future of Medicine,' Says William Haseltine
LARCHMONT, N.Y., Sep 28, 2001 (BW HealthWire) -- William A. Haseltine, Ph.D., a pioneer in the innovative field of regenerative medicine and coiner of the term, will deliver the opening address on "Regenerative Medicine: A Blueprint for the Future" at The Second Annual Conference on Regenerative Medicine. "Regenerative Medicine: Rebuilding the Human Body" is jointly sponsored by Genetic Engineering News, a division of Mary Ann Liebert, Inc., Publishers, The Society of Regenerative Medicine and USF College of Medicine, at the Renaissance Washington, D.C., Hotel on December 2-4, 2001. Dr. Haseltine, who will also chair the conference, is chairman and CEO of Human Genome Sciences, Inc., Rockville, Maryland, and president of The Regene rative Medicine Society. He will also deliver the meeting's closing commentary, "Regenerative Medicine Next Steps: The New Society."
"Medical, scientific, ethics and business leaders from around the world will assemble in Washington the first week of December to discuss the hopes, pitfalls, dilemmas, and realities of this extraordinarily promising new field of medicine," said Dr. Haseltine. "The conference, which begins with a full-day meeting on stem cells on December 2, will provide a blueprint for the future of medicine for decades to come."
The three-day conference is jointly sponsored by the University of South Florida College of Medicine, Genetic Engineering News, and The Society of Regenerative Medicine and supported by Human Genome Sciences, Inc., and BeFutur Biotechnologies. The annual symposium, first held in 2000, brings together leading researchers, scientists, physicians, and entrepreneurs in cell biology, gene therapy, and tissue engineering to share the latest advances in biocompatible materials, bioinformatics, cell and stem cell biology, cloning, embryology, genomics, organogenesis, and transplantation biology and medicine. It is the first major conference to focus on this unique approach to healing using the body's own stem cells, genes, proteins, and growth factors for repairing organs, tissues, and cells.
The 2001 symposium is chronologically divided into seven subject areas: Stem Cells, Tissue Engineering, Bioethics, Nanobiotechnology, Cloning, New Ventures, and Longevity. Session chairs and keynote speakers include Irving L. Weissman, M.D.; Stanford University; Andrew M. Yeager, M.D., University of Pittsburgh; Anthony Atala, M.D., Children's Hospital/Harvard Medical School; Arthur L. Caplan, Ph.D., University of Pennsylvania; Ian Wilmut, Ph.D., Roslin Institute, Scotland; Richard W. Siegel, Ph.D., Rennselaer Polytechnic Institute; Gunnar Weikert, M.D., Ph.D., Inventages GmbH, Germany; and Judith Campisi, Ph.D., Lawrence Berkeley National Laboratory.
A complete listing of scheduled conference events, topics, participants, and registration information, as well as details on accreditation and CME credits offered from the USF College of Medicine, is available at www.bioconferences.com/ebio.
The Society of Regenerative Medicine is dedicated to advancing the international development and dissemination of research, technology, clinical applications, appropriate public policy, and biomedical ethics in this new field of science. It was founded on the premise that many diseases and degenerative processes, including those related to aging, may be reversed or successfully treated by interventions from areas of scientific endeavor that include tissue engineering, stem cell biology, therapeutic cloning, and human gene therapy. The Society plays an active role in educating the public and members of the media to more fully understand the promise inherent in this research and the processes involved. Society members receive special conference registration discounts.
Mary Ann Liebert, Inc., is known for establishing the first peer-reviewed journals in the most promising areas of biomedical research, including Tissue Engineering, Cloning & Stem Cells, Journal of Hematotherapy & Stem Cell Research, and Human Gene Therapy. The company's biotechnology trade magazine, Genetic Engineering News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the Liebert 60 journals, books, and newsletters is available at www.liebertpub.com.
Bioconferences International Inc. Two Madison Avenue, Larchmont, NY 10538-1961 www.bioconferences.com Phone (914) 834-3100 (800) 5 - BIOCON Fax (914) 834-3689
Contact |
